Viewing Study NCT00781105


Ignite Creation Date: 2025-12-25 @ 3:36 AM
Ignite Modification Date: 2026-03-16 @ 4:13 AM
Study NCT ID: NCT00781105
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2008-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic hepatitis B View
None Adult View
None HBV DNA suppression View
None Telbivudine View